News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Next Generation Cardiac Biomarker From Critical Diagnostics Accurately Predicts Risk of Heart Failure in the General Population


11/8/2012 10:25:38 AM

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the PresageĀ® ST2 Assay, announced today that during a presentation at the American Heart Association Scientific Sessions in Los Angeles, the results of a study conducted through the Mayo Clinic and Foundation, Plasma Levels of ST2 in the Community: Association with cardiac remodeling, heart failure incidence and mortality, highlighted the remarkable accuracy of ST2 in predicting the risk of heart failure and mortality in the general population.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES